• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

    2/17/26 2:17:42 PM ET
    $CRTD
    $VTAK
    Publishing
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care
    Get the next $CRTD alert in real time by email
    • Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.
    • Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.

    • Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations.

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) announced that Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd's strategy of nurturing technology-enabled subsidiaries with scalable infrastructure and long-term value creation potential while maintaining Fly Flyte's operational independence and strategic focus. Creatd welcomes VTAK as a partner in Flyte's continued growth and success.

    "Creatd is committed to building a portfolio of operating companies in the small-cap space," said Jeremy Frommer, CEO of Creatd, Inc. "We see an opportunity to address the white space created by the contraction of middle markets over the last two decades. By integrating capabilities from banking, investing, advisory, branding, investor relations, financial analysis, and operational leverage, we can build a foundation of interlinked services to support growth-driven companies and provide pathways for them to scale or transition to listed entities."

    Fly Flyte is operational today, providing AI-enabled regional aviation services designed to increase accessibility and convenience. The company leverages certified aircraft, established routes, and scalable infrastructure to deliver real-time revenue while positioning for long-term expansion.

    About Creatd:

    Creatd, Inc. (OTCQB:CRTD) acquires and grows technology-driven companies in aviation, media, and advisory services. Through its shared services model, Creatd enables its portfolio companies to scale efficiently, improve margins, and expand market reach. For more information, visit www.creatd.com.

    Contact:

    ir@creatd.com

    Forward-Looking Statements:

    This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include all statements, other than statements of historical fact, regarding our current views and assumptions with respect to future events regarding our business and our expectations with respect to the completion of the offering, the satisfaction of customary closing conditions related to the offering and the additional closings, the anticipated use of proceeds therefrom, and other statements that are predictive in nature. These statements can be identified often, but not always, through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects," and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Such factors and risks include, among others, market and other risks, that the additional closings after today may not occur if certain closing conditions are not met, and that there can be no assurance that the Company will successfully uplist to a national securities exchange. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release contains forward-looking statements and is qualified in its entirety by, and should be read together with, the cautionary statements, risk factors and other disclosures contained in the Company's filings with the SEC and OTC Markets.



    Primary Logo

    Get the next $CRTD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRTD
    $VTAK

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $CRTD
    $VTAK
    SEC Filings

    View All

    Catheter Precision Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Catheter Precision, Inc. (0001716621) (Filer)

    6/8/26 6:16:04 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Catheter Precision Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Catheter Precision, Inc. (0001716621) (Filer)

    5/18/26 4:17:11 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Catheter Precision Inc.

    10-Q - Catheter Precision, Inc. (0001716621) (Filer)

    5/18/26 7:22:56 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $CRTD
    $VTAK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)

    ATLANTA, June 08, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), focused on making private aviation more accessible and flexible for modern travelers, today announced that it has made a strategic investment in Volato Group, Inc. (NYSE:SOAR). As part of the transaction, VTAK acquired approximately 2.9 million shares of SOAR and will own approximately 7.5% of the company's outstanding common stock. This investment provides a basis to explore potential future collaboration to improve access, efficiency, and innovation across private aviation. "This strategic investment represents an exciting opportunity for both organizations,"

    6/8/26 10:43:33 AM ET
    $SOAR
    $VTAK
    Transportation Services
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Volato Group Announces $2.2 Million Strategic Investment and AI Infrastructure Acquisition Focus

    Investment strengthens balance sheet as Company evaluates non-binding AI infrastructure and technology transaction opportunities Volato Group, Inc. (NYSE:SOAR) (the "Company" or "Volato"), a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions, today announced the signing of a definitive agreement to obtain a $2.2 million strategic investment lead by Catheter Precision, Inc. (NYSE:VTAK), and other institutional investors with experience investing in artificial intelligence and emerging technology companies. The investment of restricted common stock will strengthen Volato's balance shee

    6/8/26 6:15:00 AM ET
    $SOAR
    $VTAK
    Transportation Services
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Creatd (CRTD) Announces OG Collection, Inc. Equity Realignment as Part of Broader Uplisting Strategy

    Board-approved OG Collection transactions expected to increase Creatd's ownership from approximately 20% to 51% Realignment follows the previously announced Vocal equity realignment and Flyte transaction Transaction further strengthens Creatd's balance sheet and uplisting strategy NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) today announced that its Board of Directors has approved a targeted equity realignment and repurchase initiative with respect to its subsidiary, OG Collection, Inc., designed to restore Creatd's majority ownership. The transaction represents the next step in the Company's broader corporate turnaround, SEC re-registration process, and planned

    5/28/26 9:15:00 AM ET
    $CRTD
    Publishing
    Consumer Discretionary

    $CRTD
    $VTAK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Jenkins David A

    4 - Catheter Precision, Inc. (0001716621) (Issuer)

    3/30/26 5:58:17 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Anderson Philip J

    4 - Catheter Precision, Inc. (0001716621) (Issuer)

    3/30/26 5:58:15 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Arno Andrew

    4 - Catheter Precision, Inc. (0001716621) (Issuer)

    3/30/26 5:58:11 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $CRTD
    $VTAK
    Leadership Updates

    Live Leadership Updates

    View All

    Creatd (CRTD) Announces OG Collection, Inc. Equity Realignment as Part of Broader Uplisting Strategy

    Board-approved OG Collection transactions expected to increase Creatd's ownership from approximately 20% to 51% Realignment follows the previously announced Vocal equity realignment and Flyte transaction Transaction further strengthens Creatd's balance sheet and uplisting strategy NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) today announced that its Board of Directors has approved a targeted equity realignment and repurchase initiative with respect to its subsidiary, OG Collection, Inc., designed to restore Creatd's majority ownership. The transaction represents the next step in the Company's broader corporate turnaround, SEC re-registration process, and planned

    5/28/26 9:15:00 AM ET
    $CRTD
    Publishing
    Consumer Discretionary

    CORRECTION: Creatd Announces Vocal Equity Realignment and Updates Annual Shareholder Meeting Dates

    NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Creatd Inc., please note that two dates given in the subhead, and repeated in the body text, were not correct. The annual shareholder meeting date will be June 5, not May 26 as previously stated. The virtual annual shareholder meeting date will be July 15, not June 25 as previously stated. The corrected release follows: Board-approved Vocal transactions expected to increase Creatd's ownership from approximately 20% to 51% Annual meeting record date updated to June 5, 2026; virtual shareholder meeting will be scheduled for July 15, 2026 Vocal 3.0 remains on track as Creatd advances its

    5/14/26 11:06:11 AM ET
    $CRTD
    Publishing
    Consumer Discretionary

    Creatd Announces Vocal Equity Realignment and Updates Annual Shareholder Meeting Dates

    Board-approved Vocal transactions expected to increase Creatd's ownership from approximately 20% to 51% Annual meeting record date updated to May 26, 2026; virtual shareholder meeting will be scheduled for June 25, 2026 Vocal 3.0 remains on track as Creatd advances its SEC re-registration, corporate reorganization, and planned uplisting strategy NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) ("Creatd" or the "Company") today announced two corporate updates related to its broader reorganization and planned uplisting strategy. First, both the Company's Board of Directors and the requisite shareholders of Vocal, Inc. ("Vocal") have approved a targeted equity realignme

    5/14/26 9:15:00 AM ET
    $CRTD
    Publishing
    Consumer Discretionary

    $CRTD
    $VTAK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Catheter Precision Inc.

    SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)

    11/14/24 5:12:56 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Catheter Precision Inc.

    SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)

    11/13/24 11:14:58 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by Catheter Precision Inc.

    SC 13D/A - Catheter Precision, Inc. (0001716621) (Subject)

    10/30/24 5:26:20 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $CRTD
    $VTAK
    Financials

    Live finance-specific insights

    View All

    Creatd Finalizes 2025 Audit, Submits Amended Draft Registration Statement on Form S-1 to SEC, Ahead of Planned Uplisting and AI Acquisitions

    NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) today announced that it has finalized its audited financial statements for the fiscal year ended December 31, 2025. The completion of the 2025 audit represents a key milestone in the Company's ongoing efforts to strengthen its financial reporting framework and advance its capital markets strategy. For the fiscal year ended December 31, 2025, Creatd reported revenue of $3.2 million, compared with $1.5 million in 2024, an increase of $1.7 million approximately or 113%. The Company also reported stockholders' equity of $9 million at year-end 2025, compared with a stockholders' deficit of $10.4 million at year-end 2024, refl

    5/5/26 9:15:00 AM ET
    $CRTD
    Publishing
    Consumer Discretionary

    Catheter Precision Reports 2025 Results and Updates on Strategic Expansion

    Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year Acquisition of Flyte and Strengthened Capital Position Unlock Multi-Segment Growth Strategy with Multiple Near-Term Catalysts FORT MILL, S.C., March 31, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the fourth quarter and full year ended December 31, 2025 as well as certain other business updates. 2025: Execution Across Clin

    3/31/26 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Creatd, Inc. (OTCQB: CRTD) Announces Record Date and Annual Shareholder Meeting

    NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) ("The Company") is pleased to announce that the record date for its upcoming annual shareholder meeting is April 17, 2026. The virtual shareholder meeting is scheduled to take place on May 21, 2026. Shareholders of record as of the close of business on the record date will be entitled to notice of, and to vote at, the virtual annual meeting. Jeremy Frommer, CEO of Creatd, Inc., stated, "We are preparing to file our 2025 audited financials and complete the necessary steps to re-register with the SEC in the coming weeks. This marks the next phase of our uplisting process, following our achievement of trading above $4.00

    3/27/26 8:45:02 AM ET
    $CRTD
    Publishing
    Consumer Discretionary